These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28204972)

  • 21. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma.
    Liu C; Wang LC; Chang JF; Lin KH; Yeh YC; Hsu PK; Huang CS; Hsieh CC; Hsu HS
    Eur J Surg Oncol; 2024 Oct; 50(10):108540. PubMed ID: 39178686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Intraoperative Pulmonary Wedge Resection of Tumor Site Before Lobectomy for Early Lung Adenocarcinoma.
    Yasukawa M; Sawabata N; Kawaguchi T; Taniguchi S
    Anticancer Res; 2019 Dec; 39(12):6829-6834. PubMed ID: 31810949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical Efficacy Analysis of Wedge Resection of Pulmonary 
in Patients with Small Volume Invasive Lung Adenocarcinoma].
    Cui S; Wang G; Huang Z; Wu M; Wu H; Zhou H; Xu M; Xie M
    Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):359-366. PubMed ID: 38880923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
    Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
    Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
    Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
    Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
    Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
    Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Ann Thorac Surg; 2012 May; 93(5):1626-32. PubMed ID: 22421592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
    Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
    Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
    Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
    Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung.
    Yang HC; Kim HR; Jheon S; Kim K; Cho S; Ahn S; Lee HY; Chung JH; Chung KY; Bae MK; Park SY; Kim DK; Choi SH; Zo JI; Kim MS; Lee JM; Kim J; Shim YM; Na KJ; Yun JS; Park JY
    Ann Surg Oncol; 2015 Nov; 22(12):4089-97. PubMed ID: 25783676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection.
    Jing W; Li Q; Liu M; Zhang Y; Chen S; Zhang K; Li D; Zhao M; Zheng Y; Li W; Wu Y; Xu H; Zhao Z; Kang S; Lv F
    Cancer Imaging; 2024 Jun; 24(1):76. PubMed ID: 38886780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.